BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7889268)

  • 1. Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Canale P; Ioculano M; Campo GM; Ammendolia L; Ferlito M; Zingarelli B; Squadrito G; Saitta A
    Br J Pharmacol; 1994 Dec; 113(4):1153-8. PubMed ID: 7889268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Ioculano M; Canale P; Rossi F; Saitta A; Caputi AP
    Br J Pharmacol; 1996 Sep; 119(1):23-8. PubMed ID: 8872352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Ferlito M; Campo GM; Arlotta M; Grimaldi S; Quartarone C; Saitta A; Caputi AP
    Br J Pharmacol; 1999 May; 127(2):498-504. PubMed ID: 10385251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Saitta A; Caputi AP
    Br J Pharmacol; 1999 May; 127(2):482-8. PubMed ID: 10385249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Ferlito M; Deodato B; Arlotta M; Minutoli L; Campo GM; Bova A; Quartarone C; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 2000 May; 130(2):339-44. PubMed ID: 10807671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Minutoli L; Ferlito M; Saitta A; Caputi AP
    Eur J Pharmacol; 1998 Nov; 361(1):101-8. PubMed ID: 9851547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Arcoraci V; Minutoli L; Saitta A; Caputi AP
    Br J Pharmacol; 1997 Aug; 121(8):1782-8. PubMed ID: 9283718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.
    Squadrito F; Guarini S; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Saitta A; Cucinotta D; Bazzani C; Cainazzo MM; Mioni C; Bertolini A; Caputi AP
    Br J Pharmacol; 1999 Oct; 128(3):816-22. PubMed ID: 10516667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone prevents vascular failure mediated by nitric oxide in hemorrhagic shock.
    Zingarelli B; Caputi AP; Di Rosa M
    Shock; 1994 Sep; 2(3):210-5. PubMed ID: 7743352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte integrin very late antigen-4/vascular cell adhesion molecule-1 adhesion pathway in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Ammendolia L; Squadrito G; Campo GM; Canale P; Ioculano M; Musolino C; Alonci A; Saitta A; Rossi F; Caputi AP
    Eur J Pharmacol; 1996 Dec; 318(1):153-60. PubMed ID: 9007527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischaemia-reperfusion injury in the rat.
    Squadrito F; Altavilla D; Ammendolia L; Squadrito G; Campo GM; Sperandeo A; Canale P; Ioculano M; Saitta A; Caputi AP
    Br J Pharmacol; 1995 Jun; 115(3):395-400. PubMed ID: 7582448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Ioculano M; Ammedolia L; Arlotta M; Saitta A; Caputi AP
    Br J Pharmacol; 1997 Jan; 120(2):333-9. PubMed ID: 9117128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA; Narayanan K; Griffith OW; Kilbourn RG
    Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat.
    Squadrito F; Altavilla D; Canale P; Ioculano MP; Campo GM; Ammendolia L; Squadrito G; Saitta A; Calapai G; Caputi AP
    Br J Pharmacol; 1994 Nov; 113(3):912-6. PubMed ID: 7858885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Campo GM; Squadrito G; Saitta A; Caputi AP
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1412-7. PubMed ID: 7537468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
    McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
    Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
    Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of inhibition of nitric oxide production in a murine model of splanchnic artery occlusion shock.
    Ma XL; Johnson G; Lefer AM
    Arch Int Pharmacodyn Ther; 1991; 311():89-103. PubMed ID: 1789714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyporesponsiveness to Ca2+ of aortic smooth muscle in endotoxin-treated rats: no-dependent and -independent in vitro mechanisms.
    Ho KH; Kwan CY; Bourreau JP
    Res Commun Mol Pathol Pharmacol; 1996 Jun; 92(3):275-84. PubMed ID: 8827826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.
    Zingarelli B; Squadrito F; Ioculano M; Altavilla D; Bussolino F; Campo GM; Caputi AP
    Eur J Pharmacol; 1992 Nov; 222(1):13-9. PubMed ID: 1468489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.